Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Diagnostic Radiopharmaceuticals and Contrast Media
... estimated at US$10.2 Billion in the year 2022, is projected to reach a revised size of US$13.6 Billion by 2030, growing at aCAGR of 3.6% over the period 2022-2030. Contrast Media, one of the segments ... Read More
-
Radiopharmaceuticals Global Market Report 2023
... on radiopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... Contrast Media industry is expected to register solid growth in the sector in 2023 and beyond. The Diagnostic Radiopharmaceuticals and Contrast Media market report analyzes the Diagnostic Radiopharmaceuticals and Contrast Media market growth opportunities, trends, ... Read More
-
Radiopharmaceuticals Market Intelligence Report - Global Forecast 2023-2030
... period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this ... Read More
-
Radiopharmaceuticals Market Research Report by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Procedural Volume, Application, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Foreca
... by 2030. Cumulative Impact of COVID-19: COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during ... Read More
-
Radiopharmaceuticals Market Research Report by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Procedural Volume, Application, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast
... by 2030. Cumulative Impact of COVID-19: COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029
... in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. LPI (LP Information)' newest research ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2023-2029
... physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of ... Read More
-
Global Radiopharmaceuticals Market Growth 2023-2029
... molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging ... Read More
-
Radiopharmaceuticals
... the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer ... Read More
-
Imaging Agents
... and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact ... Read More
-
Global Nuclear Medicine or Radiopharmaceuticals Market Research Report 2022 - Market Size, Current Insights and Development Trends
... application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, ... Read More
-
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2027
... Tomography (Pet) {Flourine-18, Carbon-11, Gallium-68, And Others}], Therapeutic Products [Alpha Emitters {Astatine-211, Actinium-225, Lead-212, And Others}, Beta Emitters {Lutetium-177, Iodine-131, Yttrium-90, And Others}, And Brachytherapy]), By Application (Cardiology, Neurology, Oncology, And Others), By End-User (Hospitals, ... Read More
-
Global Theranostics Market - 2022-2029
... of 11.26% during the forecast period (2022-2029). Theranostics involves a combination of targeted diagnostic tests with targeted therapy. Theranostics include using a specific diagnostic test, which shows a distinct molecular target on a tumor or ... Read More
-
Diagnostic Radiopharmaceuticals & Contrast Media Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... This report on global diagnostic radiopharmaceuticals & contrast media market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
... market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace ... Read More
-
Global Radiopharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
... share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to ... Read More
-
Global Radiopharmaceuticals Market - 2022-2029
... period 2022 to 2029. Radiopharmaceuticals contain radioactive substances used to diagnose or treat diseases, including cancer or cardiology. These are used for the diagnosis of abscess and infection, blood vessel diseases, bone diseases, colorectal disease ... Read More
-
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19
... 2021 and expected to reach USD 1,297.11 million in 2022, and is projected to grow at a CAGR 5.82% to reach USD 1,741.84 million by 2027. Market Statistics: The report provides market sizing and forecast ... Read More
-
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
... expected to reach USD 4,851.52 million in 2022, and is projected to grow at a CAGR 6.34% to reach USD 6,610.33 million by 2027. Market Statistics: The report provides market sizing and forecast across 7 ... Read More
-
Radiopharmaceuticals Market Research Report by Type, Procedural Volume, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19
... 2021 and expected to reach USD 987.89 million in 2022, and is projected to grow at a CAGR 5.78% to reach USD 1,325.14 million by 2027. Market Statistics: The report provides market sizing and forecast ... Read More
-
Global Radiotheranostics Market By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Others), By Application (Oncology v/s Non-Oncology), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others) and By Region, Competition Forecast and Opportunities, 2027
... Biotechnology Companies, Others) and By Region, Competition Forecast and Opportunities, 2027 Global radiotheranostics market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. Radiotheranostics is a process that involves the ... Read More
-
Global SPECT Radiopharmaceuticals Market Research Report 2021-2032
... to provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “SPECT Radiopharmaceuticals Market”. Key Companies Profiled in ... Read More
-
Nuclear Medicine/Radiopharmaceuticals Market Analysis And Forecast To 2031: By Type (Diagnostics, {SPECT, PET}, Therapeutics {Alpha Emitters, Beta Emitters, Brachytherapy}), By Application (Oncology, Cardiology, Neurology, Orthopedics, Thyroid) And Region
... valued at USD 7.8 billion in 2021 and it is anticipated to grow up to USD 48.8 billion by 2031, at a CAGR of 20.1% during the forecast period. Nuclear medicine is primarily a specialized ... Read More
-
Radiopharmaceuticals & Stable Isotopes Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
... to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, ... Read More
Research Assistance
